Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

σ1 Receptor ligand binding: an open-and-shut case.

Kim FJ, Pasternak GW.

Nat Struct Mol Biol. 2018 Nov;25(11):992-993. doi: 10.1038/s41594-018-0146-1. No abstract available.

PMID:
30310147
2.

An American Association for the Surgery of Trauma (AAST) prospective multi-center research protocol: outcomes of urethral realignment versus suprapubic cystostomy after pelvic fracture urethral injury.

Moses RA, Selph JP, Voelzke BB, Piotrowski J, Eswara JR, Erickson BA, Gupta S, Dmochowski RR, Johnsen NV, Shridharani A, Blaschko SD, Elliott SP, Schwartz I, Harris CR, Borawski K, Figler BD, Osterberg EC 3rd, Burks FN, Bihrle W 3rd, Miller B, Santucci RA, Breyer BN, Flynn B, Higuchi T, Kim FJ, Broghammer JA, Presson AP, Myers JB; from the Trauma and Urologic Reconstruction Network of Surgeons (TURNS).

Transl Androl Urol. 2018 Aug;7(4):512-520. doi: 10.21037/tau.2017.11.07.

3.

Entry techniques in laparoscopic radical and partial nephrectomy: a multicenter international survey of contemporary practices.

Bove P, Iacovelli V, Sandri M, Carilli M, Cindolo L, Autorino R, Kavoussi LR, Micali S, Porpiglia F, Rha KH, Kim FJ; AGILE Group and Uro-Laparoscopic Group.

Minerva Urol Nefrol. 2018 Aug;70(4):414-421. doi: 10.23736/S0393-2249.18.03075-8. Epub 2018 Jul 3.

4.

Prostate Cancer - Local Treatment after Radiorecurrence: Salvage Cryoablation.

da Silva RD, Kim FJ.

Int Braz J Urol. 2018 May-Jun;44(3):435-439. doi: 10.1590/S1677-5538.IBJU.2018.03.05. No abstract available.

5.

The 10th anniversary of patient safety in surgery.

Stahel PF, Smith WR, Moore EE, Mehler PS, Weckbach S, Kim FJ, Butler N, Pape HC, Clarke TJ, Makary MA, Clavien PA.

Patient Saf Surg. 2017 Dec 14;11:27. doi: 10.1186/s13037-017-0145-x. eCollection 2017. No abstract available.

6.

Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1.

Maher CM, Thomas JD, Haas DA, Longen CG, Oyer HM, Tong JY, Kim FJ.

Mol Cancer Res. 2018 Feb;16(2):243-255. doi: 10.1158/1541-7786.MCR-17-0166. Epub 2017 Nov 8.

7.

Introduction to Sigma Proteins: Evolution of the Concept of Sigma Receptors.

Kim FJ.

Handb Exp Pharmacol. 2017;244:1-11. doi: 10.1007/164_2017_41. Review.

PMID:
28871306
8.

Sigma1 Pharmacology in the Context of Cancer.

Kim FJ, Maher CM.

Handb Exp Pharmacol. 2017;244:237-308. doi: 10.1007/164_2017_38. Review.

PMID:
28744586
9.

Cloning the sigma2 receptor: Wandering 40 years to find an identity.

Kim FJ, Pasternak GW.

Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):6888-6890. doi: 10.1073/pnas.1708155114. Epub 2017 Jun 23. No abstract available.

10.

Laparoscopic Versus Percutaneous Cryoablation of Small Renal Mass: Systematic Review and Cumulative Analysis of Comparative Studies.

Pessoa RR, Autorino R, Laguna MP, Molina WR, Gustafson D, Nogueira L, da Silva RD, Werahera PN, Kim FJ.

Clin Genitourin Cancer. 2017 Oct;15(5):513-519.e5. doi: 10.1016/j.clgc.2017.02.003. Epub 2017 Mar 30. Review.

PMID:
28442227
11.

A new patient safety smartphone application for prevention of "forgotten" ureteral stents: results from a clinical pilot study in 194 patients.

Molina WR, Pessoa R, Donalisio da Silva R, Kenny MC, Gustafson D, Nogueira L, Leo ME, Yu MK, Kim FJ.

Patient Saf Surg. 2017 Apr 4;11:10. doi: 10.1186/s13037-017-0123-3. eCollection 2017.

12.

Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer.

Salvino JM, Srikanth YVV, Lou R, Oyer HM, Chen N, Kim FJ.

Bioorg Med Chem Lett. 2017 May 15;27(10):2216-2220. doi: 10.1016/j.bmcl.2017.03.030. Epub 2017 Mar 18.

13.

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer.

Thomas JD, Longen CG, Oyer HM, Chen N, Maher CM, Salvino JM, Kania B, Anderson KN, Ostrander WF, Knudsen KE, Kim FJ.

Cancer Res. 2017 May 1;77(9):2439-2452. doi: 10.1158/0008-5472.CAN-16-1055. Epub 2017 Feb 24.

14.

The purpose of repurposing.

Barrett JE, Kim FJ.

Oncotarget. 2017 Feb 21;8(8):12534-12535. doi: 10.18632/oncotarget.14806. No abstract available.

15.

Why do surgeons continue to perform unnecessary surgery?

Stahel PF, VanderHeiden TF, Kim FJ.

Patient Saf Surg. 2017 Jan 13;11:1. doi: 10.1186/s13037-016-0117-6. eCollection 2017. No abstract available.

16.

Subcapsular hematoma after ureteroscopy and laser lithotripsy.

Paiva MM, da Silva RD, Jaworski P, Kim FJ, Molina WR.

Can J Urol. 2016 Aug;23(4):8385-7.

PMID:
27544565
17.

Flexible 3D laparoscopic assisted reduction and percutaneous fixation of acetabular fractures: Introduction to a new surgical option.

Mauffrey C, Hake M, Kim FJ.

Injury. 2016 Oct;47(10):2203-2211. doi: 10.1016/j.injury.2016.06.033. Epub 2016 Jun 27.

PMID:
27418454
18.

Corrigendum re: "Percutaneous Nephrolithotomy Versus Retrograde Intrarenal Surgery: A Systematic Review and Meta-analysis" [Eur Urol 2015;67:125-37].

De S, Autorino R, Kim FJ, Zargar H, Laydner H, Balsamo R, Torricelli FC, Di Palma C, Molina WR, Monga M, De Sio M.

Eur Urol. 2016 Apr;69(4):e85. doi: 10.1016/j.eururo.2015.12.046. Epub 2016 Jan 13. No abstract available.

PMID:
27301798
19.

Diffuse reflectance spectroscopy can differentiate high grade and low grade prostatic carcinoma.

Werahera PN, Jasion EA, Crawford ED, Lucia MS, van Bokhoven A, Sullivan HT, Kim FJ, Maroni PD, Port JD, Daily JW, La Rosa FG.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:5148-5151. doi: 10.1109/EMBC.2016.7591886.

PMID:
28325017
20.

Bipolar energy in the treatment of benign prostatic hyperplasia: a current systematic review of the literature.

da Silva RD, Bidikov L, Michaels W, Gustafson D, Molina WR, Kim FJ.

Can J Urol. 2015 Oct;22 Suppl 1:30-44. Review.

21.

Open Versus Laparoscopic Adrenalectomy for Adrenocortical Carcinoma: A Meta-analysis of Surgical and Oncological Outcomes.

Autorino R, Bove P, De Sio M, Miano R, Micali S, Cindolo L, Greco F, Nicholas J, Fiori C, Bianchi G, Kim FJ, Porpiglia F.

Ann Surg Oncol. 2016 Apr;23(4):1195-202. doi: 10.1245/s10434-015-4900-x. Epub 2015 Oct 19.

22.

Editorial Comment.

Kim FJ, da Silva RD.

Urology. 2015 Nov;86(5):945. doi: 10.1016/j.urology.2015.05.048. Epub 2015 Sep 3. No abstract available.

PMID:
26343238
23.

Current issues in patient safety in surgery: a review.

Kim FJ, da Silva RD, Gustafson D, Nogueira L, Harlin T, Paul DL.

Patient Saf Surg. 2015 Jun 5;9:26. doi: 10.1186/s13037-015-0067-4. eCollection 2015. Review.

24.

Focal therapy for prostate cancer: current status and future perspectives.

Miano R, Asimakopoulos AD, Da Silva RD, Bove P, Jones SJ, De La Rosette JJ, Kim FJ.

Minerva Urol Nefrol. 2015 Sep;67(3):263-80. Epub 2015 May 27. Review.

PMID:
26013953
25.

Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? - The Cancer.

Silva RD, Kim FJ.

Int Braz J Urol. 2015 Jan-Feb;41(1):5-9. doi: 10.1590/S1677-5538.IBJU.2015.01.02. No abstract available.

26.

Renal cancer management in a patient with chronic kidney disease.

Da Silva RD, Gustafson D, Nogueira L, Molina WR, Kim FJ.

Oncology (Williston Park). 2015 Mar;29(3):206-C3. No abstract available.

27.

Reply from Authors re: Thomas B.L. Lam, Sam McClinton. Between a Rock and a Hard Place: The Uncertainties in Managing Renal Stones. Eur Urol 2015;67:138-9.

Autorino R, De S, Kim FJ, Zargar H, Monga M, De Sio M.

Eur Urol. 2015 Jan;67(1):140-141. doi: 10.1016/j.eururo.2014.08.073. Epub 2014 Sep 9. No abstract available.

PMID:
29422401
28.

Perioperative Outcomes of Robotic and Laparoscopic Simple Prostatectomy: A European-American Multi-institutional Analysis.

Autorino R, Zargar H, Mariano MB, Sanchez-Salas R, Sotelo RJ, Chlosta PL, Castillo O, Matei DV, Celia A, Koc G, Vora A, Aron M, Parsons JK, Pini G, Jensen JC, Sutherland D, Cathelineau X, Nuñez Bragayrac LA, Varkarakis IM, Amparore D, Ferro M, Gallo G, Volpe A, Vuruskan H, Bandi G, Hwang J, Nething J, Muruve N, Chopra S, Patel ND, Derweesh I, Champ Weeks D, Spier R, Kowalczyk K, Lynch J, Harbin A, Verghese M, Samavedi S, Molina WR, Dias E, Ahallal Y, Laydner H, Cherullo E, De Cobelli O, Thiel DD, Lagerkvist M, Haber GP, Kaouk J, Kim FJ, Lima E, Patel V, White W, Mottrie A, Porpiglia F.

Eur Urol. 2015 Jul;68(1):86-94. doi: 10.1016/j.eururo.2014.11.044. Epub 2014 Dec 4.

29.

How I do it: laparoscopic renal cryoablation (LRC).

da Silva RD, Jaworski P, Gustafson D, Nogueira L, Kang F, Molina W, Kim FJ.

Can J Urol. 2014 Dec;21(6):7574-7.

30.

Significance of surgical plume obstruction during laparoscopy.

da Silva RD, Sehrt D, Molina WR, Moss J, Park SH, Kim FJ.

JSLS. 2014 Jul-Sep;18(3). pii: e2014.00269. doi: 10.4293/JSLS.2014.00269.

31.

Clinical use of a cordless laparoscopic ultrasonic device.

Kim FJ, Sehrt D, Molina WR, Pompeo A.

JSLS. 2014 Jul-Sep;18(3). pii: e2014.001153. doi: 10.4293/JSLS.2014.001153. Review.

32.

Editorial comment for Gözen et al.

Kim FJ.

J Endourol. 2015 Jan;29(1):99. doi: 10.1089/end.2014.0772. No abstract available.

PMID:
25389569
33.

Cyclopamine modulates γ-secretase-mediated cleavage of amyloid precursor protein by altering its subcellular trafficking and lysosomal degradation.

Vorobyeva AG, Lee R, Miller S, Longen C, Sharoni M, Kandelwal PJ, Kim FJ, Marenda DR, Saunders AJ.

J Biol Chem. 2014 Nov 28;289(48):33258-74. doi: 10.1074/jbc.M114.591792. Epub 2014 Oct 3.

34.

Evaluation of emissivity and temperature profile of laparoscopic ultrasonic devices (blades and passive jaws).

Kim FJ, Sehrt D, da Silva RD, Gustafson D, Nogueira L, Molina WR.

Surg Endosc. 2015 May;29(5):1179-84. doi: 10.1007/s00464-014-3787-0. Epub 2014 Aug 27.

PMID:
25159635
35.

Influence of saline on temperature profile of laser lithotripsy activation.

Molina WR, Silva IN, Donalisio da Silva R, Gustafson D, Sehrt D, Kim FJ.

J Endourol. 2015 Feb;29(2):235-9. doi: 10.1089/end.2014.0305. Epub 2014 Oct 10.

36.

Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis.

De S, Autorino R, Kim FJ, Zargar H, Laydner H, Balsamo R, Torricelli FC, Di Palma C, Molina WR, Monga M, De Sio M.

Eur Urol. 2015 Jan;67(1):125-137. doi: 10.1016/j.eururo.2014.07.003. Epub 2014 Jul 23. Review. Erratum in: Eur Urol. 2016 Apr;69(4):e85.

PMID:
25064687
37.

Ethnic minorities (African American and Hispanic) males prefer prostate cryoablation as aggressive treatment of localized prostate cancer.

Kim FJ, Werahera PN, Sehrt DE, Gustafson D, Silva RD, Molina WR.

Can J Urol. 2014 Jun;21(3):7305-11.

PMID:
24978362
38.

Large renal mass: a challenge for the urologist.

Da Silva RD, Molina WR, Gustafson D, Nogueira L, Tayal S, La Rosa FG, Kim FJ.

Oncology (Williston Park). 2014 Apr;28(4):320, 324. No abstract available.

39.

How I do it: prostate cryoablation (PCry).

da Silva RD, Jaworski P, Gustafson D, Nogueira L, Molina W, Kim FJ.

Can J Urol. 2014 Apr;21(2):7251-4.

40.

Highlights of the 34th Annual Ralph E. Hopkins at Jackson Hole Seminars (JHS) on February 7-12, 2014, Jackson Hole, WY, USA.

da Silva RD, Schulte MB, Miano R, Gustafson D, Nogueira L, Kim FJ.

Can J Urol. 2014 Apr;21(2):7185-7.

41.

The S.T.O.N.E. Score: a new assessment tool to predict stone free rates in ureteroscopy from pre-operative radiological features.

Molina WR, Kim FJ, Spendlove J, Pompeo AS, Sillau S, Sehrt DE.

Int Braz J Urol. 2014 Jan-Feb;40(1):23-9. doi: 10.1590/S1677-5538.IBJU.2014.01.04.

42.

Transperineal versus transrectal prostate biopsy for predicting the final laterality of prostate cancer: are they reliable enough to select patients for focal therapy? Results from a multicenter international study.

Miano R, De Nunzio C, Kim FJ, Rocco B, Gontero P, Vicentini C, Micali S, Oderda M, Masciovecchio S, Asimakopoulos AD.

Int Braz J Urol. 2014 Jan-Feb;40(1):16-22. doi: 10.1590/S1677-5538.IBJU.2014.01.03.

43.

Determinants of holmium:yttrium-aluminum-garnet laser time and energy during ureteroscopic laser lithotripsy.

Molina WR, Marchini GS, Pompeo A, Sehrt D, Kim FJ, Monga M.

Urology. 2014 Apr;83(4):738-44. doi: 10.1016/j.urology.2013.11.017. Epub 2014 Jan 31.

PMID:
24486000
44.

Laminar and turbulent surgical plume characteristics generated from curved- and straight-blade laparoscopic ultrasonic dissectors.

Kim FJ, Sehrt D, Pompeo A, Molina WR.

Surg Endosc. 2014 May;28(5):1674-7. doi: 10.1007/s00464-013-3369-6. Epub 2014 Jan 8.

PMID:
24399523
45.

Targeted Therapy for Metastatic Renal Carcinoma: an Update.

da Silva RD, Gustafson D, Nogueira L, Werahera PN, Molina WR, Kim FJ.

J Kidney Cancer VHL. 2014 Oct 21;1(6):63-73. doi: 10.15586/jkcvhl.2014.14. eCollection 2014.

46.

Histopathologic findings of small renal tumor biopsies performed immediately after cryoablation therapy: a retrospective study of 50 cases.

Tayal S, Kim FJ, Sehrt D, Miano R, Pompeo A, Molina W.

Am J Clin Pathol. 2014 Jan;141(1):35-42. doi: 10.1309/AJCP6Y3FHDLMILKT.

PMID:
24343735
47.

Outcomes of intracorporeal lithotripsy of upper tract stones is not affected by BMI and skin-to-stone distance (SSD) in obese and morbid patients.

Pompeo A, Molina WR, Juliano C, Sehrt D, Kim FJ.

Int Braz J Urol. 2013 Sep-Oct;39(5):702-9; discussion 710-1. doi: 10.1590/S1677-5538.IBJU.2013.05.13.

48.

Targeted therapy in metastatic renal carcinoma.

Mattei J, da Silva RD, Sehrt D, Molina WR, Kim FJ.

Cancer Lett. 2014 Feb 28;343(2):156-60. doi: 10.1016/j.canlet.2013.09.038. Epub 2013 Nov 13. Review.

PMID:
24239667
49.

Update in the classification and treatment of complex renal injuries.

Reis LO, Kim FJ, Moore EE, Hirano ES, Fraga GP, Nascimento B, Rizoli S.

Rev Col Bras Cir. 2013 Jul-Aug;40(4):347-50. Review. English, Portuguese.

50.

Anterior tumors of the prostate: diagnosis and significance.

Werahera PN, Crawford ED, La Rosa FG, Torkko KC, Schulte B, Sullivan HT, van Bokhoven A, Lucia MS, Kim FJ.

Can J Urol. 2013 Oct;20(5):6897-906.

Supplemental Content

Support Center